Market News (Page 1) - TendieTensor

Market News Page 1 of 157 • 3,918 articles

Augmented Reality in Packaging Market Size, Trends, Segments, Companies, Competitive Analysis, Value Chain & Trade Analysis 2025-2035

GlobeNewswire Inc. • Towards Packaging

Augmented Reality in Packaging Market Size, Trends, Segments, Companies, Competitive Analysis, Value Chain & Trade Analysis 2025-2035

12/01/2025 11:00 AM • The global augmented reality in packaging market is projected to grow from USD 383.34 billion in 2025 to USD 709.50 billion by 2034, expanding at a 6.35% CAGR. The market is driven by rising consumer demand for interactive product experiences and increasing adoption of smart technologies across industries.

BACpQ - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
MDLZ - Actively running brand-specific AR packaging campaigns to create engaging consumer experiences

#augmented reality #packaging #market growth #digital transformation #interactive experiences

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/01/2025 11:00 AM • The Schall Law Firm is pursuing a class action lawsuit against Synopsys for alleged securities fraud, claiming the company made false and misleading statements about its AI customer focus and Design IP business between December 2024 and September 2025.

BACpP - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
SNPS - The lawsuit alleges the company made false statements that negatively impacted investors, with claims that their strategic decisions around AI customers were unlikely to yield intended results, causing investor damages

#securities fraud #class action lawsuit #AI customers #Design IP

REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

GlobeNewswire Inc. • Zealand Pharma A/S

REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

12/01/2025 11:00 AM • Zealand Pharma is hosting a Capital Markets Day in London on December 11, 2025, featuring presentations from management and external experts focusing on obesity and metabolism research.

BACpO - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
ZLDPY - The company is proactively hosting an investor event, showcasing ongoing research and development in peptide-based medicines with multiple drug candidates in clinical development

#Capital Markets Day #peptide-based medicines #obesity #metabolism

Articul8 AI Achieves the AWS Agentic AI Specialization

GlobeNewswire Inc. • Arun Subramaniyan

Articul8 AI Achieves the AWS Agentic AI Specialization

12/01/2025 11:00 AM • Articul8 AI has been recognized by AWS with the Agentic AI Specialization, demonstrating expertise in developing autonomous AI systems for complex business processes across industries like financial services, manufacturing, and aerospace.

BACpN - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
AMZN - Expanding AI partner ecosystem by recognizing innovative AI startups with specialized competency programs

#Generative AI #AWS #Agentic AI #ModelMesh #Enterprise AI

Father’s Fantastical Stories of Magic Whimsy, And Life Lessons For His Kids Transformed Into An Anthology For Every Parent To Share With Their Children

GlobeNewswire Inc. • Ryan M. Graves

Father’s Fantastical Stories of Magic Whimsy, And Life Lessons For His Kids Transformed Into An Anthology For Every Parent To Share With Their Children

12/01/2025 11:00 AM • Author Ryan M. Graves releases a whimsical anthology of 30+ stories designed to share meaningful life lessons with children through imaginative narratives.

BACpM - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
AMZN - Mentioned as a sales platform for the book without additional context

#children's stories #parenting #storytelling #life lessons #imagination

Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035

GlobeNewswire Inc. • Towards Packaging

Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035

12/01/2025 11:00 AM • The European market for glass prefilled syringes and glass vials packaging equipment is projected to grow from USD 283.30 billion in 2025 to USD 389.13 billion by 2034, driven by rising demand for injectable biologics, sterile drug delivery systems, and advanced healthcare infrastructure.

BACpL - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
GRRMY - Leading German company specializing in primary packaging, focusing on prefillable syringes and vials with strong market presence

#pharmaceutical packaging #glass syringes #biologics #medical equipment #healthcare innovation

Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare

GlobeNewswire Inc. • Towards Healthcare

Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare

12/01/2025 11:00 AM • The global cell culture microcarriers market is projected to grow from USD 3.45 billion in 2025 to USD 7.2 billion by 2034, with an 8.54% CAGR, driven by advancements in biopharmaceuticals, cell therapies, and regenerative medicine research.

BACpK - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
TWST - Listed as a key market player in an expanding cell culture microcarriers market

#cell culture microcarriers #biopharmaceuticals #stem cell research #regenerative medicine #vaccine production

Goldman Sachs Bolsters Active ETF Portfolio With $2 Billion Innovator Capital Management Buy

Benzinga • Lekha Gupta

Goldman Sachs Bolsters Active ETF Portfolio With $2 Billion Innovator Capital Management Buy

12/01/2025 10:56 AM • Goldman Sachs agreed to acquire Innovator Capital Management for $2 billion in cash and equity, expanding its active ETF portfolio and positioning itself among the top ten active ETF providers globally.

BACpS - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
GS - Strategically expanding into high-growth active ETF segment, increasing market positioning and asset under management

#ETF #acquisition #asset management #investment strategy

USA Compression Seals $860 Million Deal, Adds 4.4 Million Horsepower Fleet

Benzinga • Lekha Gupta

USA Compression Seals $860 Million Deal, Adds 4.4 Million Horsepower Fleet

12/01/2025 10:36 AM • USA Compression Partners announced an $860 million acquisition of J-W Power Company, expanding its compression services fleet to 4.4 million horsepower across major U.S. energy regions, expected to close in Q1 2026.

BMLpG - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
USAC - Company is expanding operational scale, strengthening market position, and expecting immediate financial benefits through the acquisition

#acquisition #compression services #energy #natural gas #horsepower

Medical Disposable Positioning Products Market to Grow at 6.75% CAGR by 2035

GlobeNewswire Inc. • Towards Healthcare

Medical Disposable Positioning Products Market to Grow at 6.75% CAGR by 2035

12/01/2025 10:00 AM • The global medical disposable positioning products market is projected to grow from USD 1.21 billion in 2026 to USD 2.17 billion by 2035, with a 6.75% CAGR, driven by expanding healthcare applications and surgical innovations.

MMM - Prominent market player in medical disposable positioning products with strong market presence

#medical disposable positioning products #healthcare market #surgical positioning #medical devices

MPC Paris Oversees VFX and Picture Post-Production for Netflix’s Néro the Assassin

GlobeNewswire Inc. • Ryan Simper

MPC Paris Oversees VFX and Picture Post-Production for Netflix’s Néro the Assassin

12/01/2025 10:00 AM • MPC Paris, a TransPerfect studio, served as the lead VFX and post-production facility for Netflix's new eight-part original series 'Néro the Assassin', delivering 238 VFX shots and managing the entire visual effects process across eight episodes.

NFLX - Mentioned as the platform hosting the new series, with no specific performance details provided

#VFX #Netflix #visual effects #post-production #MPC Paris

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

12/01/2025 10:00 AM • The Schall Law Firm is pursuing a class action lawsuit against Marex Group for alleged securities fraud, claiming the company made false and misleading statements about its financial statements between May 16, 2024 and August 5, 2025.

MRX - The lawsuit alleges the company made false financial statements, sold over-the-counter financial products to itself, and had inconsistent financial reporting, which suggests significant corporate misconduct and potential financial irregularities

#securities fraud #class action lawsuit #financial misstatements

Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies

GlobeNewswire Inc. • Researchandmarkets.Com

Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies

12/01/2025 10:00 AM • Global tumor transcriptomics market projected to grow from $6.02 billion in 2024 to $8.71 billion by 2030, driven by rising cancer prevalence and genomic sequencing advancements, with spatial transcriptomics emerging as a key technological trend.

TER - Expecting 27% year-over-year growth driven by AI applications and strong memory performance
TMO - Highlighted as a key market player in a growing market with significant projected expansion

#tumor transcriptomics #cancer research #genomic sequencing #spatial transcriptomics #molecular biology

Micron’s $338 Target: The AI Memory Supercycle Is Just Starting

Investing.com • Jeffrey Neal Johnson

Micron’s $338 Target: The AI Memory Supercycle Is Just Starting

12/01/2025 09:45 AM • Morgan Stanley raised Micron's price target to $338, signaling strong confidence in the company's potential during the AI-driven memory supercycle, driven by high demand for High-Bandwidth Memory (HBM) in AI infrastructure.

BAC - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
MU - Strong financial performance with 49% revenue increase, gross margin expansion from 22% to 41%, and strategic positioning in AI memory market with Data Center business now representing 56% of total revenue

#AI #semiconductor #memory chips #HBM #infrastructure

Why Is Small-Cap Q32 Bio Stock Soaring On Monday?

Benzinga • Vandana Singh

Why Is Small-Cap Q32 Bio Stock Soaring On Monday?

12/01/2025 09:43 AM • Q32 Bio sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics for $12 million in upfront payments, with potential milestone payments up to $592 million, causing its stock to surge by over 115%.

BACpB - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
QTTB - Received significant upfront payment, retained rights to other assets, and stock price increased dramatically after the deal

#biotech #drug development #acquisition #complement inhibitor #milestone payments

Nvidia Just Delivered Amazing News to Investors for 2026

The Motley Fool • Adria Cimino

Nvidia Just Delivered Amazing News to Investors for 2026

12/01/2025 09:35 AM • Nvidia continues to dominate the AI chip market, with projected hyperscaler infrastructure spending reaching $600 billion in 2026, signaling strong potential growth and continued market leadership in artificial intelligence technology.

BACpE - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
NVDA - Demonstrated explosive growth from $27B to $130B annual revenue, leading AI chip market, strong projected infrastructure spending, and 1,200% stock price gain over five years

#AI #chips #hyperscalers #infrastructure spending #GPU #technology

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

GlobeNewswire Inc. • Meng Li

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

12/01/2025 09:00 AM • Avalon GloboCare expanded its KetoAir™ breathalyzer device internationally to the UK, launched a first responder wellness program in Nevada, and showcased its metabolic health monitoring technology at a London summit.

FpC - Committed $5 billion to EV investments, indicating continued market growth potential
ALBT - Company demonstrated growth through international market entry, new health program launch, and technology showcase, indicating positive business momentum

#KetoAir #metabolic health #breathalyzer #wellness #international expansion

Arqit Quantum Inc. Sets Fiscal year 2025 Conference Call for Tuesday, December 9, 2025 at 11:00 a.m. ET

GlobeNewswire Inc. • Arqit Quantum Inc.

Arqit Quantum Inc. Sets Fiscal year 2025 Conference Call for Tuesday, December 9, 2025 at 11:00 a.m. ET

12/01/2025 09:00 AM • Arqit Quantum Inc. will report its fiscal year 2025 financial results on December 9, 2025, hosting a conference call with CEO Andy Leaver and CFO Nick Pointon to discuss the company's performance.

FpB - Committed $5 billion to EV investments, indicating continued market growth potential
ARQQ - The article is a standard financial conference call announcement without strong positive or negative indicators, presenting routine corporate communication about upcoming financial reporting

#quantum encryption #financial results #conference call #cybersecurity

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

GlobeNewswire Inc. • Neonc Technologies Holdings, Inc.

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

12/01/2025 09:00 AM • NeOnc Technologies revealed preclinical research demonstrating that ultrasound can enhance the therapeutic potency of NEO100 for treating primary and metastatic brain tumors, using an AI-driven 3D-bioprinted methodology.

F - Committed $5 billion to EV investments, indicating continued market growth potential
NTHI - The company presented promising research showing potential breakthrough in brain tumor treatment using AI and ultrasound technology, which could significantly expand their commercial and clinical opportunities

#AI #ultrasound #brain tumors #sonodynamic therapy #3D bioprinting

Dr. Fidelio Tata Joins Seda Experts in Germany as a Leading Expert in Financial Markets and the Investment Industry

GlobeNewswire Inc. • Dr. Fidelio Tata

Dr. Fidelio Tata Joins Seda Experts in Germany as a Leading Expert in Financial Markets and the Investment Industry

12/01/2025 09:00 AM • Dr. Fidelio Tata, an internationally recognized finance expert with nearly 30 years of experience, has joined SEDA Experts LLC as Managing Director, bringing extensive expertise from top Wall Street firms and current academic work in finance.

HSBC - Mentioned as a previous employer of Dr. Tata with no specific positive or negative context

#financial markets #expert witness #derivatives #investment industry #finance professor

Off The Hook Yachts Reminds Boat Buyers that the “One Big Beautiful Bill” Reinstated 100% Bonus Depreciation for Boats Bought By January 19, 2026

GlobeNewswire Inc. • Jason Ruegg

Off The Hook Yachts Reminds Boat Buyers that the “One Big Beautiful Bill” Reinstated 100% Bonus Depreciation for Boats Bought By January 19, 2026

12/01/2025 09:00 AM • Off The Hook Yachts is reminding U.S. boat buyers about the 'One Big Beautiful Bill Act' which reinstates 100% bonus depreciation for qualifying business boats through January 19, 2026, allowing eligible buyers to deduct the entire purchase price in the first year if used over 50% for business purposes.

REGN - Successful collaborative development of Dupixent, promising clinical trial results, potential expansion of drug's approved indications
OTH - Company is proactively informing customers about a beneficial tax opportunity that could boost their business and customer interest

#bonus depreciation #boat purchase #tax incentive #business assets

UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale

Benzinga • Vandana Singh

UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale

12/01/2025 08:46 AM • UnitedHealth Group has agreed to sell its remaining South American operation, Banmedica, to Brazilian private equity firm Patria Investments for $1 billion, continuing its strategy to streamline operations and exit Latin American markets.

FpD - Committed $5 billion to EV investments, indicating continued market growth potential
UNH - The company is strategically divesting its South American assets after experiencing significant financial losses, indicating a calculated restructuring effort to improve overall business performance

#divestment #healthcare #South America #private equity #asset sale

Leggett & Platt Shares Surge On Somnigroup Acquisition Proposal

Benzinga • Lekha Gupta

Leggett & Platt Shares Surge On Somnigroup Acquisition Proposal

12/01/2025 08:43 AM • Somnigroup International proposed an all-stock acquisition of Leggett & Platt at $12.00 per share, representing a 30.3% premium to its 30-day average closing price.

TSLA - Planning significant EV production and capital spending ramp-up in 2026
LEG - Stock price surged 10.58% on acquisition proposal with significant premium

#acquisition #merger #stock transaction #premium

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire Inc. • Solid Biosciences Inc.

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

12/01/2025 08:00 AM • Solid Biosciences received FDA Rare Pediatric Disease designation for SGT-212, a dual-route gene therapy targeting Friedreich's ataxia. The therapy aims to restore frataxin protein levels and address neurologic, cardiac, and systemic disease manifestations.

SLDB - Company received important FDA designations (Rare Pediatric Disease and Fast Track) for its investigational gene therapy, indicating promising progress in developing a treatment for a rare genetic disorder

#gene therapy #Friedreich's ataxia #FDA designation #rare disease

ProQR to Participate in 8th Annual Evercore Healthcare Conference

GlobeNewswire Inc. • Proqr Therapeutics N.V.

ProQR to Participate in 8th Annual Evercore Healthcare Conference

12/01/2025 08:00 AM • ProQR Therapeutics will participate in the 8th Annual Evercore Healthcare Conference, presenting its Axiomer™ RNA editing technology platform that enables targeted single nucleotide changes in RNA to potentially develop new disease treatments.

PRQR - Company is presenting innovative RNA editing technology, announcing conference participation, and highlighting potential for developing new medical treatments across diverse disease types

#RNA therapy #Axiomer #RNA editing #ADAR #biotechnology